MJRIC
BBH icon

Mogy Joel R Investment Counsel’s VanEck Biotech ETF BBH Stock Holding History

Mogy Joel R Investment Counsel’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36,880
Closed -$5.76M – 106
2023
Q2 		$5.76M Buy
36,880
+481
+1% +$76.8K 0.46% 38
2023
Q1 		$5.9M Buy
36,399
+1,179
+3% +$191K 0.52% 38
2022
Q4 		$5.63M Buy
35,220
+1,013
+3% +$160K 0.56% 37
2022
Q3 		$4.82M Sell
34,207
-939
-3% -$142K 0.5% 39
2022
Q2 		$5.12M Buy
35,146
+330
+0.9% +$49.2K 0.51% 40
2022
Q1 		$5.64M Buy
34,816
+1,145
+3% +$185K 0.45% 39
2021
Q4 		$6.38M Buy
33,671
+2,635
+8% +$508K 0.46% 41
2021
Q3 		$6.27M Buy
31,036
+1,619
+6% +$340K 0.51% 37
2021
Q2 		$5.93M Buy
29,417
+1,580
+6% +$294K 0.5% 37
2021
Q1 		$4.88M Buy
27,837
+2,847
+11% +$515K 0.47% 39
2020
Q4 		$4.24M Buy
24,990
+120
+0.5% +$19.8K 0.42% 40
2020
Q3 		$4.03M Buy
24,870
+500
+2% +$81.3K 0.43% 40
2020
Q2 		$3.97M Buy
24,370
+2,447
+11% +$372K 0.48% 39
2020
Q1 		$2.81M Sell
21,923
-2,286
-9% -$308K 0.4% 44
2019
Q4 		$3.38M Buy
24,209
+210
+0.9% +$27.6K 0.4% 44
2019
Q3 		$2.83M Buy
23,999
+1,245
+5% +$155K 0.36% 48
2019
Q2 		$2.94M Buy
22,754
+1,595
+8% +$197K 0.38% 46
2019
Q1 		$2.72M Buy
21,159
+2,454
+13% +$310K 0.37% 46
2018
Q4 		$2.07M Buy
18,705
+1,340
+8% +$162K 0.32% 52
2018
Q3 		$2.36M Buy
17,365
+1,270
+8% +$165K 0.32% 55
2018
Q2 		$1.93M Buy
16,095
+940
+6% +$111K 0.29% 58
2018
Q1 		$1.82M Buy
15,155
+1,040
+7% +$131K 0.28% 60
2017
Q4 		$1.76M Buy
14,115
+9,525
+208% +$1.22M 0.28% 63
2017
Q3 		$616K Buy
4,590
+1,720
+60% +$224K 0.1% 91
2017
Q2 		$361K Buy
2,870
+695
+32% +$83.8K 0.06% 104
2017
Q1 		$259K Buy
+2,175
New +$254K 0.04% 112

Other funds holding BBH

MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIG
Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mogy Joel R Investment Counsel's BBH Position: Q3 2023 in Review

Mogy Joel R Investment Counsel sold out of VanEck Biotech ETF (BBH) in Q3 2023, closing a stake of 36,880 shares — an estimated $5.76M sold.

Mogy Joel R Investment Counsel first reported a position in BBH in Q1 2017 and held it in 26 quarters. The position peaked at $6.38M in Q4 2021. 110 funds tracked by Wall St. Rank hold BBH as of Q3 2023.

  • Mogy Joel R Investment Counsel reported no remaining VanEck Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Mogy Joel R Investment Counsel sold 36,880 VanEck Biotech ETF shares in Q3 2023, an estimated $5.76M.
  • Mogy Joel R Investment Counsel first reported a position in VanEck Biotech ETF in Q1 2017 and held it in 26 quarters.
  • Mogy Joel R Investment Counsel's VanEck Biotech ETF position peaked at $6.38M in Q4 2021.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2023.

Based on Mogy Joel R Investment Counsel's 13F filing for Q3 2023, filed 1 Nov 2023.